These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 19573938

  • 1. Mortality and morbidity of newly diagnosed heart failure with preserved systolic function treated with β-blockers: a propensity-adjusted case-control populational study.
    Gomez-Soto FM, Romero SP, Bernal JA, Escobar MA, Puerto JL, Andrey JL, Almenara J, Gomez F.
    Int J Cardiol; 2011 Jan 07; 146(1):51-5. PubMed ID: 19573938
    [Abstract] [Full Text] [Related]

  • 2. Prognosis of heart failure with preserved ejection fraction treated with β-blockers: A propensity matched study in the community.
    Ruiz G, Andrey JL, Puerto JL, Escobar MA, Romero SP, Aranda R, Pedrosa MJ, Gomez F.
    Int J Cardiol; 2016 Nov 01; 222():594-602. PubMed ID: 27513657
    [Abstract] [Full Text] [Related]

  • 3. Mortality and morbidity of newly diagnosed heart failure treated with statins: a propensity-adjusted cohort study.
    Gomez-Soto FM, Romero SP, Bernal JA, Escobar MA, Puerto JL, Andrey JL, Ruiz P, Gomez F.
    Int J Cardiol; 2010 Apr 15; 140(2):210-8. PubMed ID: 19106008
    [Abstract] [Full Text] [Related]

  • 4. Mortality and morbidity of non-systolic heart failure treated with angiotensin-converting enzyme inhibitors: a propensity-adjusted case-control study.
    Gomez-Soto FM, Romero SP, Bernal JA, Escobar MA, Puerto JL, Andrey JL, Almenara J, Gomez F.
    Int J Cardiol; 2010 Mar 18; 139(3):276-82. PubMed ID: 19064293
    [Abstract] [Full Text] [Related]

  • 5. Mortality of newly diagnosed heart failure treated with amiodarone A propensity-matched study.
    Andrey JL, Gomez-Soto FM, Romero SP, Escobar MA, García-Egido AA, Garcia-Arjona R, Gomez F, GAMIC (Grupo para Atencion Medica Integrada de Cadiz).
    Int J Cardiol; 2011 Sep 01; 151(2):175-81. PubMed ID: 20550974
    [Abstract] [Full Text] [Related]

  • 6. Effect of beta blocker therapy on survival of patients with heart failure and preserved systolic function following hospitalization with acute decompensated heart failure.
    Nevzorov R, Porath A, Henkin Y, Kobal SL, Jotkowitz A, Novack V.
    Eur J Intern Med; 2012 Jun 01; 23(4):374-8. PubMed ID: 22560389
    [Abstract] [Full Text] [Related]

  • 7. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC, Stough WG, Abraham WT, Albert NM, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB, OPTIMIZE-HF Investigators and Hospitals.
    J Am Coll Cardiol; 2007 Aug 21; 50(8):768-77. PubMed ID: 17707182
    [Abstract] [Full Text] [Related]

  • 8. Mortality and morbidity of heart failure treated with digoxin. A propensity-matched study.
    Andrey JL, Romero S, García-Egido A, Escobar MA, Corzo R, Garcia-Dominguez G, Lechuga V, Gómez F.
    Int J Clin Pract; 2011 Dec 21; 65(12):1250-8. PubMed ID: 22093531
    [Abstract] [Full Text] [Related]

  • 9. Differences in outcome of heart failure with preserved or depressed systolic function in patients older than 70 years who receive beta blockers.
    Anguita M, Castillo JC, Ruiz M, Castillo F, Jiménez-Navarro M, Crespo M, Alonso-Pulpón L, de Teresa E, Castro-Beiras A, Roig E, Artigas R, Zapata A, de Ullibarri IL, Muñiz J, OBELICA Study Researchers.
    Rev Esp Cardiol (Engl Ed); 2012 Jan 21; 65(1):22-8. PubMed ID: 22001308
    [Abstract] [Full Text] [Related]

  • 10. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
    Pascual-Figal DA, Redondo B, Caro C, Manzano S, Garrido IP, Ruipérez JA, Valdés M.
    Am J Cardiol; 2008 Dec 15; 102(12):1711-7. PubMed ID: 19064029
    [Abstract] [Full Text] [Related]

  • 11. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice.
    Go AS, Yang J, Gurwitz JH, Hsu J, Lane K, Platt R.
    Arch Intern Med; 2008 Dec 08; 168(22):2415-21. PubMed ID: 19064823
    [Abstract] [Full Text] [Related]

  • 12. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
    Jost A, Rauch B, Hochadel M, Winkler R, Schneider S, Jacobs M, Kilkowski C, Kilkowski A, Lorenz H, Muth K, Zugck C, Remppis A, Haass M, Senges J, HELUMA study group.
    Eur Heart J; 2005 Dec 08; 26(24):2689-97. PubMed ID: 16183697
    [Abstract] [Full Text] [Related]

  • 13. Treatment of heart failure with preserved systolic function.
    de Groote P, Herpin D, Diévart F, Hanon O, Trochu JN, Artigou JY, Galinier M, Habib G, Juillière Y, Neuder Y, Roudaut R, Komajda M.
    Arch Cardiovasc Dis; 2008 May 08; 101(5):361-72. PubMed ID: 18656095
    [Abstract] [Full Text] [Related]

  • 14. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R, Wang Y, Foody JM.
    Am J Cardiol; 2008 Jan 15; 101(2):217-22. PubMed ID: 18178410
    [Abstract] [Full Text] [Related]

  • 15. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.
    Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, ADHERE Scientific Advisory Committee and Investigators.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):76-84. PubMed ID: 16386668
    [Abstract] [Full Text] [Related]

  • 16. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH, Benson L, Dahlström U, Edner M, Friberg L.
    JAMA; 2014 Nov 19; 312(19):2008-18. PubMed ID: 25399276
    [Abstract] [Full Text] [Related]

  • 17. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Shlipak MG.
    Circulation; 2006 Jun 13; 113(23):2713-23. PubMed ID: 16754803
    [Abstract] [Full Text] [Related]

  • 18. Population-based analysis of class effect of β blockers in heart failure.
    Lazarus DL, Jackevicius CA, Behlouli H, Johansen H, Pilote L.
    Am J Cardiol; 2011 Apr 15; 107(8):1196-202. PubMed ID: 21349489
    [Abstract] [Full Text] [Related]

  • 19. Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS).
    Chan JD, Rea TD, Smith NL, Siscovick D, Heckbert SR, Lumley T, Chaves P, Furberg CD, Kuller L, Psaty BM.
    Am Heart J; 2005 Sep 15; 150(3):464-70. PubMed ID: 16169325
    [Abstract] [Full Text] [Related]

  • 20. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP, Albanese MC, De Biaggio P, Rozbowsky P, Miani D, Fresco C, Fioretti PM.
    J Am Soc Echocardiogr; 2004 Mar 15; 17(3):253-61. PubMed ID: 14981424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.